A61K 47/02
Inorganic compounds
A61K47/02 (Inorganic compounds) appears on 5,619 US grants and 10,460 published applications in this corpus.
Search patents in A61K- Granted patents
- 5,619
- Published applications
- 10,460
- Assignees
- 3,963
- Inventors
- 16,241
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 8 | 0 |
| 1977 | 5 | 0 |
| 1978 | 9 | 0 |
| 1979 | 14 | 0 |
| 1980 | 5 | 0 |
| 1981 | 8 | 0 |
| 1982 | 6 | 0 |
| 1983 | 8 | 0 |
| 1984 | 10 | 0 |
| 1985 | 4 | 0 |
| 1986 | 12 | 0 |
| 1987 | 11 | 0 |
| 1988 | 7 | 0 |
| 1989 | 16 | 0 |
| 1990 | 13 | 0 |
| 1991 | 14 | 0 |
| 1992 | 22 | 0 |
| 1993 | 9 | 0 |
| 1994 | 10 | 0 |
| 1995 | 8 | 0 |
| 1996 | 18 | 0 |
| 1997 | 24 | 0 |
| 1998 | 36 | 0 |
| 1999 | 42 | 0 |
| 2000 | 31 | 0 |
| 2001 | 66 | 30 |
| 2002 | 56 | 82 |
| 2003 | 59 | 126 |
| 2004 | 43 | 146 |
| 2005 | 39 | 126 |
| 2006 | 33 | 134 |
| 2007 | 36 | 129 |
| 2008 | 28 | 121 |
| 2009 | 35 | 128 |
| 2010 | 77 | 216 |
| 2011 | 58 | 215 |
| 2012 | 98 | 199 |
| 2013 | 133 | 303 |
| 2014 | 199 | 387 |
| 2015 | 215 | 485 |
| 2016 | 291 | 547 |
| 2017 | 299 | 600 |
| 2018 | 328 | 588 |
| 2019 | 341 | 674 |
| 2020 | 424 | 741 |
| 2021 | 434 | 875 |
| 2022 | 387 | 845 |
| 2023 | 434 | 765 |
| 2024 | 467 | 714 |
| 2025 | 427 | 693 |
| 2026 | 262 | 591 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for laser lithotripsy using nanoparticle fine-tuned NIR absorption6 Oct 2026US 12,751,766 B2Duke University
- Ketamine formulation6 Oct 2026US 12,751,918 B2Fresenius Kabi USA, LLC
- Stable levothyroxine compositions in aprotic polar solvents6 Oct 2026US 12,751,937 B2Xeris Pharmaceuticals, Inc.
- Stable pharmaceutical compositions of edaravone and dextrocamphol6 Oct 2026US 12,751,941 B2Jiangsu Simcere Pharmaceutical Co., Ltd.
- Injectable formulations in a method for treating pain6 Oct 2026US 12,751,943 B2Pelthos Therapeutics Inc.
- Suspension containing heterocyclidene acetamide derivative8 Oct 2026US 2026/0306401 A1Mochida Pharmaceutical Co., Ltd.
- Aqueous formulations comprising fullerene, structured water, dissolved hydrogen gas, minerals and additives8 Oct 2026US 2026/0306402 A1Best Planet Science LLC
- Compositions for the effective treatment of vitamin c deficiency-related diseases and other conditions8 Oct 2026US 2026/0306447 A1
- N-n-dimethyltryptamine (dmt) and dmt analog oral transmucosal film compositions, methods of making, and methods of use thereof8 Oct 2026US 2026/0306454 A1
- Stable pharmaceutical compositions of clonidine8 Oct 2026US 2026/0306456 A1Azurity Pharmaceuticals, Inc.
Most cited
By later US patents
- Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents638US 6,383,471 B1Lipocine Inc. · 2002
- Preparation for treatment of spinal cord injury541US 9,040,062 B2Keio University · 2015
- Hydrogel for the therapeutic treatment of aneurysms446US 6,113,629 AMicrus Corporation · 2000
- Method for treatment of cancer by inhibiting the immunosuppressive signal induced by PD-1328US 7,595,048 B2Ono Pharmaceutical Co., Ltd. · 2009
- Method of reducing TNF.alpha. levels with amino substituted 2-(2,6-dioxopiperidin-3-yl)-1-oxo-and 1,3-dioxoisoindolines288US 5,635,517 ACelgene Corporation · 1997